Utah Medical Products (UTMD) Receivables (2010 - 2026)

Utah Medical Products' Receivables history runs 17 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• In Q1 2026, Receivables fell 7.81% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (down 7.81% YoY), while the FY2025 annual figure was $3.5 million, down 16.91% from the prior year.
• Receivables was $3.6 million for Q1 2026 at Utah Medical Products, up from $3.5 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $6.0 million in Q3 2022 to a low of $3.4 million in Q4 2023.
• Historically, Receivables has averaged $4.1 million across 5 years, with a median of $3.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Receivables soared 37.6% in 2022, then tumbled 42.21% in 2023.
• A 5-year view of Receivables shows it stood at $5.6 million in 2022, then slumped by 39.33% to $3.4 million in 2023, then advanced by 25.01% to $4.2 million in 2024, then retreated by 16.91% to $3.5 million in 2025, then rose by 3.24% to $3.6 million in 2026.
• The last three Receivables figures came in at $3.6 million (Q1 2026), $3.5 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.